• Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Bachem Holding AG

+ Add to Watchlist


48.70 CHF 0.20 0.41%

As of 11:43:41 ET on 08/27/2014.

Snapshot for Bachem Holding AG (BANB)

Open: 48.50 Day's Range: 48.50 - 48.95 Volume: 905
Previous Close: 48.50 52wk Range: 39.73 - 50.90 1-Yr Rtn: +8.66%

Stock Chart for BANB

No chart data available.
  • BANB:SW 48.70
  • 1D
  • 1M
  • 1Y
Interactive BANB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BANB

Current P/E Ratio (ttm) 27.8286
Estimated P/E(12/2014) 24.6208
Relative P/E vs. SMI 1.3857
Earnings Per Share (CHF) (ttm) 1.7500
Est. EPS (CHF) (12/2014) 1.9780
Est. PEG Ratio -
Market Cap (M CHF) 662.32
Shares Outstanding (M) 6.80
30 Day Average Volume 1,622
Price/Book (mrq) 1.9546
Price/Sale (ttm) 3.8567
Dividend Indicated Gross Yield 3.59%
Cash Dividend (CHF) 1.7500
Dividend Ex-Date 04/30/2014
5 Year Dividend Growth -11.37%
Next Earnings Announcement 08/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BANB

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for BANB

Bachem Holding AG manufactures ingredients for pharmaceuticals, generic drugs, and research supplies. The Company produces peptides and amino-acids for medications and laboratory research, and prescription medicines that are no longer patent protected. Bachem sells its products to universities, and pharmaceutical and biotechnology companies.

Thomas FruehChairman-Mgmt Board/CEOStephan SchindlerCFO-Member Mgmt Board
Daniel ErneCTO-Member Mgmt BoardJose De ChastonayCMO-Member Mgmt Board
More Company Profile & Key Executives for BANB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil